Sep 07, 2017 7:00 am EDT Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Jun 28, 2017 7:00 am EDT Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award
Jun 05, 2017 7:59 am EDT Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting
May 11, 2017 7:15 am EDT Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017